Voyager Therapeutics(VYGR) - 2021 Q3 - Quarterly Report

Table of Contents FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Commission file number: 001-37625 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Voyager Therapeutics, Inc. (Exact name of Registrant as specified in its charter) For the quarterly period ended September 30, 2021 Delaware 46-3003182 (State or other jurisdiction of incorporation or organization) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC ...